Enzyme to arrest bacteria cell growth discovered

It opens up fresh ways to target microbes, leading to a new wave of antibiotic drugs

Updated - April 03, 2019 12:08 am IST

Published - April 03, 2019 12:07 am IST - HYDERABAD

CCMB director Rakesh Mishra, left, Manjula Reddy and research scholar Ch. Pavan Kumar in Hyderabad.

CCMB director Rakesh Mishra, left, Manjula Reddy and research scholar Ch. Pavan Kumar in Hyderabad.

Scientists at the Centre for Cellular & Molecular Biology (CCMB) have discovered a new enzyme which helps in breaking cell walls of bacteria and hence, offers a potential for a new drug delivery route to arrest the anti-bacterial resistance through existing antibiotic drugs.

At a press conference here on Tuesday, CCMB director Rakesh Mishra and senior scientist Manjula Reddy explained that it is crucial to know how cells grow in bacteria to understand the anti-bacterial resistance to currently available antibiotics.

Scientists all over the world are trying to understand this phenomenon and the lab of Dr. Reddy has been working on how e. coli bacteria cells function, divide and grow to understand diseases like cholera, leprosy, tuberculosis and so on for the past decade.

Principal players

Dr. Reddy and her research scholar Ch. Pavan Kumar have been working on how the cell governs the synthetic machinery to build the cell wall in the first place, identified the principal players behind the process and discovered the new mechanism or enzyme through which the cell regulates growth of its wall.

Blocking function

Other bacteria, too, have the same enzyme working on cell division as the cell wall is fundamental for bacterial growth and division. Therefore, by blocking this ‘scissors enzyme’ from functioning, new ways to target microbes could be found, leading to a new wave of antibiotic drugs.

In contrast, the classical antibiotic drugs target the last stage of cell synthesis to prevent cell growth like penicillin that hits the machinery that creates the cell wall — a mesh-like structure of cross-linked sugars and peptides.

New combination

“What has been found is very novel. Now the next step is to find out the molecule of the enzyme endo-pepcidine and it has to be followed by the drug trials to unravel a new combination of drugs to replace existing antibiotics though it is difficult to forecast a time frame,” said Dr. Mishra and Dr. Reddy.

The findings have been published in the latest issue of Proceedings of National Academy of Sciences, USA .

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.